Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P
- PMID: 1371034
- DOI: 10.1016/0002-8703(92)90638-c
Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P
Abstract
The objective of this study was to determine if endothelium-dependent vasodilation is preserved in the spastic segment of the epicardial coronary artery. Segmental responses of the coronary artery to substance P were examined by the use of a quantitative angiographic technique in 21 patients with variant angina. Coronary diameter at the basal state did not differ between the spastic and the nonspastic segments (2.3 +/- 0.2 mm, 2.3 +/- 0.4 mm, p greater than 0.05). Changes in coronary diameter in response to substance P did not differ between segments with ergonovine-induced spasm and nonspastic segments. Maximal dilation averaged 27.1 +/- 9.5% in the spastic segment and 24.4 +/- 9.6% in the nonspastic segment (expressed as a percent increase over the value before drug administration). It appears that both the potential of the endothelium to release endothelium-dependent relaxing factor and the dilating response of the smooth muscle to endothelium-dependent relaxing factor are preserved, even in the spastic segment.
Similar articles
-
Preserved endothelial function in the spastic segment of the human epicardial coronary artery in patients with variant angina--role of substance P in evaluating endothelial function.Eur Heart J. 1993 Nov;14 Suppl I:118-22. Eur Heart J. 1993. PMID: 7507436
-
Endothelium-dependent dilator response to substance P in patients with coronary spastic angina.J Am Coll Cardiol. 1992 Oct;20(4):838-44. doi: 10.1016/0735-1097(92)90181-l. J Am Coll Cardiol. 1992. PMID: 1382082
-
Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo.Circulation. 1995 Jul 15;92(2):183-9. doi: 10.1161/01.cir.92.2.183. Circulation. 1995. PMID: 7600649
-
In vivo measurement of endothelium-dependent vasodilation with substance P in man.Herz. 1992 Oct;17(5):284-90. Herz. 1992. PMID: 1282120 Review.
-
Endothelial function and coronary spastic angina.Intern Med. 2005 Feb;44(2):91-9. doi: 10.2169/internalmedicine.44.91. Intern Med. 2005. PMID: 15750267 Review.
Cited by
-
Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and vasospastic angina.Clin Cardiol. 1997 Oct;20(10):873-6. doi: 10.1002/clc.4960201015. Clin Cardiol. 1997. PMID: 9377825 Free PMC article.
-
Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity.Eur Cardiol. 2020 Apr 6;15:e12. doi: 10.15420/ecr.2019.20. eCollection 2020 Feb. Eur Cardiol. 2020. PMID: 32373185 Free PMC article. Review.
-
Invasive Evaluation for Coronary Vasospasm.US Cardiol. 2023 Jun 9;17:e07. doi: 10.15420/usc.2022.33. eCollection 2023. US Cardiol. 2023. PMID: 39493950 Free PMC article. Review.
-
[Coronary spasm--a clinically relevant problem?].Herz. 1998 Mar;23(2):106-15. doi: 10.1007/BF03044541. Herz. 1998. PMID: 9592706 Review. German.
-
Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.Br J Pharmacol. 1994 Dec;113(4):1099-104. doi: 10.1111/j.1476-5381.1994.tb17109.x. Br J Pharmacol. 1994. PMID: 7889260 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources